Rivaroxaban monotherapy in patients with pulmonary embolism: off-label vs. labeled therapy

HIGHLIGHTS

  • who: Pierpaolo Di Micco and collaborators from the UOC Medicina y Urgencia-ASL NAPOLI , Nord Ospedale Anna Rizzoli Lacco Ameno, Naples, Italy Department of Medicine and Surgery, Insubria University, Varese, Italy have published the article: Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy, in the Journal: (JOURNAL)
  • what: This analysis is aimed at assessing the real-world effectiveness and safety of rivaroxaban in real-world patients with acute PE. The aim of this study was to assess the clinical characteristics of PE patients who received off-label rivaroxaban, and to compare . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?